COVID-19 vaccine hesitancy and acceptance in Mexico: a web-based nationwide survey

Abstract

Objective. To identify factors associated with COVID-19 vaccine hesitancy and acceptance among the Mexican population. Methods. In a web-based nationwide survey in early December 2020, respondents were inquired about their sociodemographic characteristics and their willingness to accept a hypothetical COVID-19 vaccine given a 50% or 90% effectiveness. A logistic regression model was used to identify the factors associated with hesitancy and acceptance. Results. A total 3 768 responses were analyzed. A 90% effective vaccine was accepted by 85% of respondents, while only 46% would accept being vaccinated with a 50% effective vaccine. In univariate analysis, each age group (40–49, 50–59, and ≥60) was strongly associated with vaccine hesitancy for a 90% effective vaccine (OR 0.48, 95% CI 0.38, 0.63; OR 0.33, 95 CI 0.26, 0.41; and OR 0.28, 95 CI 0.21, 0.38, respectively) compared to the 18–39 age group. After multivariable adjustment, similar magnitudes of association were observed. Being female and higher socioeconomic status were also associated with higher vaccine hesitancy. Conclusions. Vaccine hesitancy represents a major public health problem in Mexico and is driven by multiple factors. Our study provides relevant insights for the development of effective policies and strategies to ensure widespread vaccination in Mexico.

Is Mexico's population hesitant towards COVID-19 vaccines? A 2021 survey on different levels of hesitancy and its determinants

“…As in previous studies, our research identified a subpopulation of vaccine-hesitant people in Mexico ( Fig. 2 C), albeit markedly smaller than those of other countries such as the United States (52.1%) or Russia (55.1%; Carnalla et al, 2021 ; Delgado-Gallegos et al, 2021 ; Ramonfaur et al, 2021 ; Sallam, 2021 ). The percentage of people with no VH (51.9%) was lower than that reported in other studies, such as those by Delgado-Gallegos et al (87.8%) or by Ramonfaur et al (85%; Delgado-Gallegos et al, 2021 ; Ramonfaur et al, 2021 ).…”

“…2 C), albeit markedly smaller than those of other countries such as the United States (52.1%) or Russia (55.1%; Carnalla et al, 2021 ; Delgado-Gallegos et al, 2021 ; Ramonfaur et al, 2021 ; Sallam, 2021 ). The percentage of people with no VH (51.9%) was lower than that reported in other studies, such as those by Delgado-Gallegos et al (87.8%) or by Ramonfaur et al (85%; Delgado-Gallegos et al, 2021 ; Ramonfaur et al, 2021 ). To understand this discrepancy, we must consider that all of them—including the present study—have limitations; for example, those studies were conducted before the vaccine rollout in Mexico and only considered VH as absent or present.…”

“…Thankfully, we are not completely in the dark on this issue. Last year, some population studies on COVID-19 vaccine hesitancy were conducted in Mexico at different time intervals, reporting different proportions of the population as unwilling to receive a COVID-19 vaccine ( Carnalla et al, 2021 ; Center for Geospatial Information Science University of; Delgado-Gallegos et al, 2021 ; Lazarus et al, 2021 ; Maryland, 2021; Ramonfaur et al, 2021 ; Sallam, 2021 ). However, more research that deepens our knowledge on this subject is necessary to effectively tackle this issue.…”

Determinant Factors of COVID-19 Vaccine Hesitancy Among Adult and Elderly Population in Central Java, Indonesia

“…Having comorbidity was the prominent variable associated with higher vaccine acceptance. 30 , 42 On the contrary, this study showed having comorbidity was more likely to have COVID-19 vaccine hesitancy. In Indonesia, misinformation about the safety of COVID-19 vaccines has existed since vaccines were not available, such as disinformation and perceived vaccine unsafety for an individual having pre-existing comorbid conditions.…”

“…Vaccine willingness decreases as vaccine effectiveness decreases. 20 , 30 Respondents who did not believe in the vaccine halalness were significantly more at risk of having vaccine hesitancy than the respondents having a belief in its halalness. Being a country with a Muslim majority population, a religious-based view about the halalness of COVID-19 vaccines could influence the vaccine’s acceptance.…”